The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011
Open accessAbstract
IMPORTANCE: Inappropriate antimicrobial drug use is associated with adverse events in hospitalized patients and contributes to the emergence and spread of resistant pathogens. Targeting effective interventions to improve antimicrobial use in the acute care setting requires understanding hospital prescribing practices. OBJECTIVE: To determine the prevalence of and describe the rationale for antimicrobial use in participating hospitals. DESIGN, SETTING, AND PARTICIPANTS: One-day prevalence surveys were conducted in acute care hospitals in 10 states between May and September 2011. Patients were randomly selected from each hospital's morning census on the survey date. Data collectors reviewed medical records retrospectively to gather data on antimicrobial drugs administered to patients on the survey date and the day prior to the survey date, including reasons for administration, infection sites treated, and whether treated infections began in community or health care settings. MAIN OUTCOMES AND MEASURES: Antimicrobial use prevalence, defined as the number of patients receiving antimicrobial drugs at the time of the survey divided by the total number of surveyed patients. RESULTS: Of 11,282 patients in 183 hospitals, 5635 (49.9%; 95% CI, 49.0%-50.9%) were administered at least 1 antimicrobial drug; 77.5% (95% CI, 76.6%-78.3%) of antimicrobial drugs were used to treat infections, most commonly involving the lower respiratory tract, urinary tract, or skin and soft tissues, whereas 12.2% (95% CI, 11.5%-12.8%) were given for surgical and 5.9% (95% CI, 5.5%-6.4%) for medical prophylaxis. Of 7641 drugs to treat infections, the most common were parenteral vancomycin (1103, 14.4%; 95% CI, 13.7%-15.2%), ceftriaxone (825, 10.8%; 95% CI, 10.1%-11.5%), piperacillin-tazobactam (788, 10.3%; 95% CI, 9.6%-11.0%), and levofloxacin (694, 9.1%; 95% CI, 8.5%-9.7%). Most drugs administered to treat infections were given for community-onset infections (69.0%; 95% CI, 68.0%-70.1%) and to patients outside critical care units (81.6%; 95% CI, 80.4%-82.7%). The 4 most common treatment antimicrobial drugs overall were also the most common drugs used for both community-onset and health care facility-onset infections and for infections in patients in critical care and noncritical care locations. CONCLUSIONS AND RELEVANCE: In this cross-sectional evaluation of antimicrobial use in US hospitals, use of broad-spectrum antimicrobial drugs such as piperacillin-tazobactam and drugs such as vancomycin for resistant pathogens was common, including for treatment of community-onset infections and among patients outside critical care units. Further work is needed to understand the settings and indications for which reducing antimicrobial use can be most effectively and safely accomplished.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Self-citationClinical practice guidelines for antimicrobial prophylaxis in surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120568 · Cited by 2,591
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 1×
“Data Collection Data collectors reviewed medical records on the survey date to determine whether patients may have been receiving enteral (excluding rectal), intravenous, intramuscular, or inhaled antimicrobial drugs (eMethods 1 in the Supplement) at the time of the survey, using the following screening criteria: (1)…”
Gaieski, D. F., Mikkelsen, M. E., Band, R. A., Pines, J. M., Massone, R., Furia, F. F., Shofer, F. S., & Goyal, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4824 · Cited by 970 · cited 1×
“Data Collection Data collectors reviewed medical records on the survey date to determine whether patients may have been receiving enteral (excluding rectal), intravenous, intramuscular, or inhaled antimicrobial drugs (eMethods 1 in the Supplement) at the time of the survey, using the following screening criteria: (1)…”
Iregui, M., Ward, S., Sherman, G., Fraser, V. J., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.122.1.262 · Cited by 956
Pollack, L. A., & Srinivasan, A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu542 · Cited by 574
Stulberg, J. J. (2010) · JAMA · doi:10.1001/jama.2010.841 · Cited by 529
Hecker, M. T., Aron, D. C., Patel, N. P., Lehmann, M. K., & Donskey, C. J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.972 · Cited by 495
Dantes, R. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10423 · Cited by 452
Vital signs: improving antibiotic use among hospitalized patients.
Fridkin, S. K., Baggs, J. M., Fagan, R. P., Magill, S. S., Pollack, L. A., Malpiedi, P. J., Slayton, R. B., Khader, K., Rubin, M. A., Jones, M., et al. (2014) · PubMed Central · Cited by 401
Self-citationVariability in Antibiotic Use at Children's Hospitals
Gerber, J. S., Newland, J. G., Coffin, S. E., Hall, M., Thurm, C., Prasad, P. A., Feudtner, C., & Zaoutis, T. E. (2010) · Pediatrics · doi:10.1542/peds.2010-1275 · Cited by 215
Swaminathan, M., Sharma, S., Blash, S. P., Patel, G., Banach, D. B., Phillips, M., LaBombardi, V., Anderson, K. F., Kitchel, B., Srinivasan, A., et al. (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/671270 · Cited by 179
Trends in Antibacterial Use in US Academic Health Centers: 2002 to 2006
Pakyz, A. L., MacDougall, C., Oinonen, M., & Polk, R. E. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2254 · Cited by 162
Avdic, E., Cushinotto, L., Hughes, A. H., Hansen, A. R., Efird, L. E., Bartlett, J. G., & Cosgrove, S. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis242 · Cited by 146
Marchaim, D., Chopra, T., Bhargava, A., Bogan, C., Dhar, S., Hayakawa, K., Pogue, J. M., Bheemreddy, S., Blunden, C. E., Shango, M. M., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/666642 · Cited by 128
Antibiotic Use at Duke University Medical Center
Castle, M. A. (1977) · JAMA · doi:10.1001/jama.1977.03270530027016 · Cited by 119
Fridkin, S. K., & Srinivasan, A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit710 · Cited by 107
Self-citationThe Perpetual Challenge of Antimicrobial Resistance
Fauci, A. S., & Marston, H. D. (2014) · JAMA · doi:10.1001/jama.2014.2465 · Cited by 99
Shorr, A. F., Myers, D. E., Huang, D. B., Nathanson, B. H., Emons, M. F., & Kollef, M. H. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-268 · Cited by 84
Schouten, J. A., Hulscher, M., Liefers, J., Akkermans, R., Kullberg, B. J., Grol, R. P. T. M., & van der Meer, J. W. M. (2007) · Clinical Infectious Diseases · doi:10.1086/512193 · Cited by 73
Polgreen, P. M., Chen, Y., Cavanaugh, J. E., Ward, M., Coffman, S. L., Hornick, D. B., Diekema, D. J., & Herwaldt, L. A. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512174 · Cited by 71
Berríos-Torres, S. I., Yi, S. H., Bratzler, D. W., Ma, A., Mu, Y., Zhu, L., & Jernigan, J. A. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675289 · Cited by 64
Huttner, B. D., Jones, M., Huttner, A., Rubin, M. A., & Samore, M. H. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt171 · Cited by 46
Beyond surgical care improvement program compliance: antibiotic prophylaxis implementation gaps
Hawkins, R. B., Levy, S. M., Senter, C. E., Zhao, J. Y., Doody, K., Kao, L. S., Lally, K. P., & Tsao, K. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.02.009 · Cited by 37
Jinno, S., Chang, S., & Donskey, C. J. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.10.010 · Cited by 20
Zilberberg, M. D., Chaudhari, P., Nathanson, B. H., Campbell, R. S., Emons, M. F., Fiske, S., Hays, H. D., & Shorr, A. F. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-154 · Cited by 17
Cited by
Association of adverse events with antibiotic use in hospitalized patients.
Tamma, P. D., Avdic, E., Li, D. X., Dzintars, K., & Cosgrove, S. E. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1938 · Cited by 800
Versporten, A., Zarb, P., Caniaux, I., Gros, M.-F., Drapier, N., Miller, M., Jarlier, V., Nathwani, D., Goossens, H., Koraqi, A., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30186-4 · Cited by 671
Kaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., & Jernigan, J. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5651 · Cited by 268
Self-citationKent, A. G., Vill, A. C., Shi, Q., Satlin, M. J., & Brito, I. L. (2020) · Nature Communications · doi:10.1038/s41467-020-18164-7 · Cited by 216
Metadata
- Authors
- Magill, S. S., Edwards, J. R., Beldavs, Z. G., Dumyati, G., Janelle, S. J., Kainer, M. A., Lynfield, R., Nadle, J., Neuhauser, M. M., Ray, S. M., Richards, K., Rodriguez, R., Thompson, D. L., & Fridkin, S. K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-10-08
- Volume
- 312
- Issue
- 14
- Pages
- 1438
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2132117678
- Cited by
- 350
- References
- 28
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.